Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3243-3253

  Wang, Hong Ying ^a   Xin, Zhicheng ^a   Tang, Hao ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; DRUG STABILITY; FEMALE; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; T-LYMPHOCYTES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029883204     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. O'Dorisio, M. S., T. O'Dorisio, S. Cotland, and S. P. Bakerzak. 1980. VIP as a biochemical marker for PMNs. J. Lab. Clin. Med. 96:666.
2. Lygren, I., A. Revhaug, P. G. Burhol, K. E. Giercksky, and T. G. Jenssen. 1984. VIP and SOM in leukocytes. Scand. J. Clin. Lab. Invest. 44:347.
3. Felten, D. L., S. Y. Felten, J. A. Carlson, J. A. Olschowka, and S. Livnat. 1985. Noradrenergic and peptidergic innervation of lymphoid organs. J. Immunol. 135: 755s.
4. Ottaway, C. A., D. L. Lewis, and S. L. Asa. 1987. VIP-containing nerves in Peyer's patches. Brain Behav. Immun. 1:148.
5. Fink, T., and E. Weihe. 1988. Multiple neuropeptides in nerves supplying mammalian lymph nodes. Neurosci. Lett. 90:31.
6. Lundberg, J. M., A. Anggard, J. Pernow, and T. Hokfelt. 1985. NPY, SP, and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control. Cell Tissue Res. 239:9.
7. Goetzl, E. J., K. T. Kodama, C. W. Turck, S. Shiogolev, and S. P. Sreedharan. 1989. Unique pattern of cleavage of VIP by human lymphocytes. Immunology 66:554.
8. Gomariz, R. P., M. J. Lorenzo, L. Caciedo, A. Vicente, and A. G. Zapata. 1990. Demonstration of IR-VIP and IR-SOM in rat thymus. Brain Behav. Immun. 4:151.
9. Weinstock, J. V., and A. M. Blum. 1990. Detection of VIP and localization of its mRNA within granulomas of murine schistosomiasis. Cell. Immunol. 125:291.
10. Weihe, E., D. Nohr, S. Michel, S. Muller, H. J. Zentel, T. Fink, and J. Krekel. 1991. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59:1.
11. Gomariz, R. P., M. De La Fuente, A. Hernanz, and J. Leceta. 1992. Occurrence of VIP in lymphoid organs from rat and mouse. Ann. NY Acad. Sci. 650:13.
12. Gomariz, R. P., M. Delgado, J. R. Naranjo, B. Mellstrom, A. Tormo, F. Mata, and J. Leceta. 1993. VIP gene expression in rat thymus and spleen. Brain Behav. Immun. 7:271.
13. Krammer, H. J., and W. Kuhnel. 1993. Topography of the enteric nervous system in Peyer's patches of the porcine small intestine. Cell Tissue Res. 272:267.
14. Gomariz, R. P., J. Leceta, E. Garrido, T. Garrido, and M. Delgado. 1994. VIP mRNA expression in rat T and B lymphocytes. Regul. Pept. 50:177.
15. Leceta, J., M. C. Martinez, M. Delgado, E. Garrido, and R. P. Gomariz. 1994. Lymphoid cell subpopulations containing vasoactive intestinal peptide in the rat. Peptides 15:794.
16. Moore, T. C., C. H. Spruck, and S. I. Said. 1988. Depression of lymphocyte traffic in sheep by VIP. Immunology 64:475.
17. Robichon, A., S. P. Sreedharan, J. Yang, R. S. Shames, E. C. Gronroos, P. P. J. Cheng, and E. J. Goetzl. 1993. Induction of aggregation of Raji human B cells by VIP. Immunology 79:574.
18. De la Fuente, M., M. Delgado, M. DelRio, E. Garrido, J. Leceta, A. Hernanz, and R. P. Gomariz. 1994. VIP modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. Peptides 15:1157.
19. Ottaway, C. A., and G. R. Greenberg. 1984. Interaction of VIP with mouse lymphocytes. J. Immunol. 132:417.
20. Krco, T. J., A. Gores, and V. L. W. Go. 1986. Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Clin. Immunol. Immunopathol. 39:308.
21. Ottaway, C. A. 1987. Selective effects of VIP on the mitogenic response of murine T cells. Immunology 62:291.
22. Boudard, F., and M. Bastide. 1991. Inhibition of mouse T cell proliferation by CGRP and VIP. J. Neurosci. Res. 29:29.
23. Tang, S. C., H. Braunsteiner, and C. J. Wiedermann. 1992. Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide. Immunol. Lett. 34:237.
24. Xin, Z., H. Tang, and D. Ganea. 1994. VIP inhibits IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54: 59.
25. Stanitz, A. M., D. Befus, and J. Bienenstock. 1986. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on Ig synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. J. Immunol. 136:152.
26. Rola-Pleszczynski, M., D. Bolduc, and S. St-Pierre. 1985. The effects of VIP on NK function. J. Immunol. 135:4078.
27. Wiik, P. 1989. VIP inhibits the respiratory burst in human monocytes by a cAMP-mediated mechanism. Regul. Pept. 25:187.
28. De La Fuente, M., M. Delgado, M. Del Rio, C. Martinez, A. Hernanz, and R. P. Gomariz. 1993. Stimulation by VIP of phagocytic function in rat macrophages: involvement of PKC activity. Regul. Pept. 48:345.
29. Ichinose, M., M. Sawada, and T. Maeno. 1994. Inhibitory effect of VIP on phagocytosis in mouse peritoneal macrophages. Regul. Pept. 54:457.
30. Beed, E. A., M. S. O'Dorisio, T. M. O'Dorisio, and T. S. Gaginella. 1983. Demonstration of a functional receptor for VIP on Molt 4b T lymphoblasts. Regul. Pept. 6:1.
31. Finch, R. J., S. P. Sreedharan, and E. J. Goetzl. 1989. High affinity receptors for VIP on human myeloma cells. J. Immunol. 142:1977.
32. O'Dorisio, M. S., B. T. Shannon, D. J. Fleishman, and L. B. Campolito. 1989. Identification of high affinity receptors for VIP on human lymphocytes of the B lineage. J. Immunol. 142:3533.
33. Ottaway, C. A., T. E. Lay, and G. R. Greenberg. 1990. High affinity specific binding of VIP to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29:149.
34. Blum, A. M., R. Mathew, G. A. Cook, A. Metwali, R. Felman, and J. V. Weinstock. 1992. Murine mucosal T cells have VIP receptors functionally distinct from those on epithelial cells. J. Neuroimmunol. 39:101.
35. Cheng, P. P. J., S. P. Sreedharan, J. L. Kishiyama, and E. J. Goetzl. 1993. The SKW 6.4 line of human B lymphocytes specifically binds and responds to VIP. Immunology 79:64.
36. Calvo, J. J., M. L. Montilla, J. M. Guerrero, and J. J. Segura. 1994. Expression of VIP receptors in mouse peritoneal macrophages. J. Neuroimmunol. 50:85.
37. Gomariz, R. P., E. Garrido, J. Leceta, C. Martinez, R. Abalo, and M. Delgado. 1994. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1599.
38. Mathew, R. C., G. A. Cook, A. M. Blum, A. Metwali, R. Felman, and J. V. Weinstock. 1992. VIP stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection. J. Immunol. 148:3572.
39. Ganea, D., and L. Sun. 1993. VIP down-regulates the expression of IL-2 but not of TFN-γ from stimulated murine T lymphocytes. J. Neuroimmunol. 47:147.
40. Nio, D. A., R. N. Moylan, and J. K. Roche. 1993. Modulation of T lymphocyte function by neuropeptides. J. Immunol. 150:5281.
41. Sun, L., and D. Ganea. 1993. VIP inhibits IL-2 and IL-4 production through different mechanisms in T cells activated via the TCR/CD3 complex. J. Neuroimmunol. 48:59.
42. Tang, H., A. Welton, and D. Ganea. 1995. Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553. J. Interferon Cytokine Res. 15:993.
43. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
44. Powers, G. D., A. K. Abbas, and R. A. Miller. 1988. Frequencies of IL-2 and IL-4 secreting T cells in naive and antigen-stimulated lymphocyte populations. J. Immunol. 140:3352.
45. Ben-Sasson, S. Z., G. LeGors, D. H. Conrad, F. D. Finkelman, and W. E. Paul. 1990. IL-4 production by T cells from naive donors: IL-2 is required for IL-4 production. J. Immunol. 145:1127.
46. Cardell, S., and B. Sander. 1990. IL-2, 4, and 5 are sequentially produced in mitogen-stimulated murine spleen cell cultures. Eur. J. Immunol. 20:389.
47. Tada, H., O. Shiho, K. Kuroshima, M. Koyama, and K. Tsukamoto. 1986. An improved colorimetric assay for interleukin 2. J. Immunol. Methods 93:157.
48. Kriegel, M., C. Perez, K. deFay, L. Albert, and S. D. Lu. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45.
49. Isolation and analysis of proteins. In Current Protocols in Immunology. 1995. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 8.12.1.
50. Mosmann, T. R., J. H. Schumacher, D. F. Fiorentino, J. Leverah, K. W. Moore, and M. W. Bond. 1990. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6 and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol. 145:2938.
51. Montgomery, R. A., and M. J. Dallman. 1991. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J. Immunol. 147:554.
52. Mosmann, T. R., H. Cherwinsky, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clones: definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
53. Kurt-Jones, E. A., S. Hamberg, J. Ohara, W. E. Paul, and A. K. Abbas. 1987. Heterogeneity of helper/inducer T lymphocytes: lymphokine production and lymphokine responsiveness. J. Exp. Med. 166:1774.
54. Scott, P. 1991. IFNγ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
55. + T cells. Eur. J. Immunol. 24: 343.
56. Swain, S. I., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
57. Schmitt, E., R. van Brandwijk, H. G. Fischer, and E. Rude. 1990. Establishment of different T cell sublines using either IL-2 or IL-4 as growth factors. Eur. J. Immunol. 20:1709.
58. Monteyne, P., J. C. Renauld, and J. P. Coutelier. 1992. Differential regulation of phorbol myristate acetate of IFNγ and IL-4 expression in anti-CD3 stimulated mouse spleen cells. Immunology 75:206.
59. Holter, W., O. Majdic, F. S. Kalthoff, and W. Knapp. 1992. Regulation of IL-4 production in human mononuclear cells. Eur. J. Immunol. 22:2765.
60. Lichtman, A. H., E. A. Kurt-Jones, and A. K. Abbas. 1987. B-cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc. Natl. Acad. Sci. USA 84:1421.
61. O'Dorisio, M. S., N. S. Hermina, T. M. O'Dorisio, and P. Balcerzak. 1981. VIP stimulation of adenylate cyclase in purified human leukocytes. J. Immunol. 127: 2551.
62. O'Dorisio, M. S., C. L. Wood, D. Wenger, and L. M. Vassalo. 1985. Cyclic AMP-dependem protein kinase in MOLT 4B lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI). J. Immunol. 134:4078.
63. Robberecht, P., J. Abello, C. Damien, P. De Neef, E. Vervisch, R. Hooghe, and J. Christophe. 1989. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptide and β-adrenergic agonist in murine T-cell lymphomas of immature, helper, and cytotoxic types. Immunobiology 179:422.
64. Segura, J. J., J. M. Guerrero, R. Goberna, and J. R. Calvo. 1992. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages. Regal. Pept. 37:195.
65. Tang, H., L. Sun, Z. Xin, and D. Ganea. 1995. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Ann. NY Acad. Sci. In press.
66. Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353.
67. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148:2845.
68. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267:23301.
69. Snijdewint, F. G. M., M. L. Kapsenberg, P. J. J. Wauber-Penris, and J. D. Bos. 1995. Corticosteroids class-dependently inhibit in vitro Th1- and Th2-type cytokine production. Immunopharmacology 29:93.
70. Coffman, R. L., B. W. Seymour, D. A. Lebman, D. D. Hiraki, J. A. Christiansen, B. Shrader, H. M. Cherwinski, H. F. J. Saverkoul, F. D. Finkelman, M. W. Bond, and T. R. Mosmann. 1988. The role of helper T cell products on mouse B cell differentiation and isotype regulation. Immunol. Rev. 102:5.
71. Burger, D., and J. M. Dayer. 1995. Inhibitory cytokines and cytokine inhibitors. Neurology 45:539.